Newsfeeds - Spark Newswire

1 minute read

Repro-Med Systems Q2 EPS $(0.02), Inline, Sales $5.50M Beat $5.39M Estimate

Today, 7:22 PM

Repro-Med Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 200 percent decrease over earnings of $0.02 per share from the same period last year.

KRMD

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

Today, 7:22 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

11 minute read

Earnings Scheduled For August 11, 2021

By Benzinga Insights

Today, 7:22 PM

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.

ACVA

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 7:22 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

5 minute read

Uncategorized

77 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:22 PM

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52.

AHPI

1 minute read

Uncategorized

Recap: Repro-Med Systems Q1 Earnings

By Benzinga Insights

Today, 7:22 PM

Shares of Repro-Med Systems (NASDAQ:KRMD) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 100.00% over the past year to ($0.00), which beat the estimate of ($0.01).

KRMD

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

Today, 7:22 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

9 minute read

Uncategorized

Earnings Scheduled For May 12, 2021

By Benzinga Insights

Today, 7:22 PM

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.

ADMA

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 7:22 PM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL